Literature DB >> 15352381

MAO activity in serotonergic endings of rat major cerebral arteries.

A L López de Pablo1, M Ajubita, M C F Criado, E J Marco.   

Abstract

The present work studies the existence of monoamine oxidase (MAO) activity in serotonergic endings present in rat major cerebral arteries. Enzymatic activity was appraised in vivo by serotonin (5-HT) accumulation or 5-hydroxyindole acetic acid (5-HIAA) disappearance with time after systemic administration of MAO inhibitors. Pargyline (75 mg/Kg, ip) brought about significant 5-HT increase and 5-HIAA decrease in major cerebral arteries 30 and 60 min after its administration. Clorgyline (75 mg/Kg, ip) also induced 5-HT enhancement and 5-HIAA decline in these arteries 30 and 60 min after its injection. However, treatment with deprenyl (75 mg/Kg, ip) only evoked a significant 5-HT increase at 60 min. When either clorgyline (5 mg/Kg, ip) or deprenyl (5 mg/Kg, ip) were administered 5-HT and 5-HIAA levels remained unaffected. Two weeks after performing electrolytical lesion of dorsal raphe nucleus and 60 min after clorgyline (75 mg/Kg, ip) injection 5-HT and 5-HIAA levels appeared significantly reduced in cerebral arteries and striatum when compared to sham-lesioned controls. These results suggest that MAO-A isoform acting on endogenous 5-HT is present in rat major cerebral arteries and is located in nerve endings of fibers arising from dorsal raphe nucleus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15352381     DOI: 10.1007/bf03168217

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  19 in total

1.  MAO-A and MAO-B activities in rat striatum, frontal cortex and liver are unaltered after long-term treatment with fluvoxamine and desipramine.

Authors:  H Silver; M B Youdim
Journal:  Eur Neuropsychopharmacol       Date:  2000-03       Impact factor: 4.600

2.  Cervical gangliectomy does not affect in vitro tryptophan hydroxylase activity in rat brain base arteries.

Authors:  M J Moreno; A L López de Pablo; E J Marco
Journal:  Brain Res       Date:  1997-02-21       Impact factor: 3.252

3.  Serotonin, nerves, and cerebral blood vessels.

Authors:  P Aubineau; P Mathiau
Journal:  Stroke       Date:  1995-01       Impact factor: 7.914

4.  Monoamine oxidase-containing nerve fibers in the major cerebral arteries of rats.

Authors:  K Shigematsu; I Akiguchi; N Oka; H Kamo; K Matsubayashi; M Kameyama; J Kawamura; T Maeda
Journal:  Brain Res       Date:  1989-09-11       Impact factor: 3.252

5.  Localization of monoamine oxidase A and B mRNA in the rat brain by in situ hybridization.

Authors:  J W Jahng; T A Houpt; T C Wessel; K Chen; J C Shih; T H Joh
Journal:  Synapse       Date:  1997-01       Impact factor: 2.562

6.  Evidence for differing origins of the serotonergic innervation of major cerebral arteries and small pial vessels in the rat.

Authors:  G Bonvento; P Lacombe; E T MacKenzie; D Fage; J Benavides; L Rouquier; B Scatton
Journal:  J Neurochem       Date:  1991-02       Impact factor: 5.372

7.  Tryptophan hydroxylase activity in rat brain base arteries related to innervation originating from the dorsal raphe nucleus.

Authors:  M J Moreno; A L López de Pablo; E J Marco
Journal:  Stroke       Date:  1994-05       Impact factor: 7.914

8.  Cerebrovascular nerve fibers immunoreactive for tryptophan-5-hydroxylase in the rat: distribution, putative origin and comparison with sympathetic noradrenergic nerves.

Authors:  Z Cohen; G Bovento; P Lacombe; J Seylaz; E T MacKenzie; E Hamel
Journal:  Brain Res       Date:  1992-12-11       Impact factor: 3.252

9.  Measurement of 5-hydroxytryptamine turnover rate in rat cerebral arteries.

Authors:  J C Soto; E J Marco
Journal:  J Pharm Pharmacol       Date:  1988-03       Impact factor: 3.765

10.  Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives.

Authors:  L A Mamounas; C A Mullen; E O'Hearn; M E Molliver
Journal:  J Comp Neurol       Date:  1991-12-15       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.